CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression
"CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Carolyn Jean Presley (ORCID: https://orcid.org/0000-0002-2607-5639)
- Jacob J. Kaufman
- Adam Khorasanchi (ORCID: https://orcid.org/0000-0002-4603-376X)
- Logan Roof (ORCID: https://orcid.org/0000-0002-9362-7851)
- Asrar A. Alahmadi (ORCID: https://orcid.org/0000-0001-7385-2843)
- Daniel Spakowicz (ORCID: https://orcid.org/0000-0003-2314-6435)
- Jinesh Gheeya (ORCID: https://orcid.org/0000-0002-5246-6262)
- Po‐Lan Su (ORCID: https://orcid.org/0000-0002-8470-6590)
- Mingjia Li (ORCID: https://orcid.org/0000-0002-3910-4179)
- Natalie Johns
- Kenneth Chian
- David P. Carbone (ORCID: https://orcid.org/0000-0003-3002-1921)
- Christian Rolfo (ORCID: https://orcid.org/0000-0002-5109-0267)
- Regan M. Memmott (ORCID: https://orcid.org/0000-0001-5881-9252)
- Alexander Rudich (ORCID: https://orcid.org/0009-0005-1264-9936)
- Peter G. Shields (ORCID: https://orcid.org/0000-0002-7404-217X)
- Kai He (ORCID: https://orcid.org/0000-0002-5805-3354)
- Dwight Hall Owen (ORCID: https://orcid.org/0000-0002-6598-4886)
- Songzhu Zhao
- Lai Wei (ORCID: https://orcid.org/0009-0008-6761-3158)
Institutions
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- The Ohio State University (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7160
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00